Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Enfusion Stock News

ENFNNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$9.01

-1.58-14.92%

Pre-Market: 8:22 AM EDT

Enfusion (ENFN) Forecast

News

Earnings Enfusion (ENFN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Enfusion Stock News | NYSE:ENFN | Benzinga

Get the latest news on Enfusion stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Enfusion performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 02, 2025

Clearwater Analytics and Enfusion Releases El...
Benzinga Newsdesk - 4 days ago

Thursday, February 27, 2025

Reported Earlier, Clearwater-Enfusion Deal Pr...
Benzinga Newsdesk - Feb 27, 2025, 2:23AM

Friday, January 17, 2025

12 Information Technology Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jan 17, 2025, 4:05PM
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jan 17, 2025, 7:05AM

Monday, January 13, 2025

William Blair Downgrades Enfusion to Market P...
Benzinga Newsdesk - Jan 13, 2025, 2:23PM
Clearwater Analytics to Acquire Enfusion for ...
Benzinga Newsdesk - Jan 13, 2025, 6:41AM

Thursday, January 02, 2025

This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts
Avi Kapoor - Jan 2, 2025, 7:45AM

Monday, December 30, 2024

This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Avi Kapoor - Dec 30, 2024, 7:45AM

Friday, December 27, 2024

Sell Alert: Bradley Herring Cashes Out $259K In Enfusion Stock
Benzinga Insights - Dec 27, 2024, 10:02AM

Monday, December 23, 2024

Piper Sandler Maintains Neutral on Enfusion, ...
Benzinga Newsdesk - Dec 23, 2024, 7:28AM

Thursday, December 19, 2024

12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Dec 19, 2024, 4:06PM

Wednesday, December 18, 2024

Stifel Maintains Buy on Enfusion, Raises Pric...
Benzinga Newsdesk - Dec 18, 2024, 12:13PM

Tuesday, December 03, 2024

Neal Pawar Executes Sell Order: Offloads $190K In Enfusion Stock
Benzinga Insights - Dec 3, 2024, 10:01AM

Monday, November 04, 2024

Enfusion Narrows FY2024 Sales Guidance from $...
Benzinga Newsdesk - Nov 4, 2024, 7:40AM
Enfusion Q3 Adj $0.05 Misses $0.06 Estimate, ...
Benzinga Newsdesk - Nov 4, 2024, 7:35AM

Friday, September 20, 2024

Enfusion shares are trading higher after the ...
Benzinga Newsdesk - Sep 20, 2024, 2:32PM
Enfusion Is Interviewing Investment Banks To ...
Benzinga Newsdesk - Sep 20, 2024, 1:47PM

Tuesday, August 06, 2024

Enfusion Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks - Aug 6, 2024, 3:56PM
Enfusion Continues To Expect FY24 GAAP Revenu...
Benzinga Newsdesk - Aug 6, 2024, 7:48AM
Enfusion Q2 2024 Adj. EPS $0.05 Misses $0.06 ...
Benzinga Newsdesk - Aug 6, 2024, 7:39AM

Thursday, May 09, 2024

Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Es...
Benzinga Newsdesk - May 9, 2024, 7:34AM

Thursday, March 14, 2024

Watching Enfusion; Spruce Point Capital Manag...
Benzinga Newsdesk - Mar 14, 2024, 9:32AM
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Mar 14, 2024, 9:06AM

Wednesday, March 13, 2024

A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
Benzinga Insights - Mar 13, 2024, 10:04AM
B of A Securities Maintains Underperform on E...
Benzinga Newsdesk - Mar 13, 2024, 8:10AM

Tuesday, March 12, 2024

Enfusion shares are trading higher after the ...
Benzinga Newsdesk - Mar 12, 2024, 10:56AM
Enfusion Expects 2024 Revenue of $200M-$210M ...
Benzinga Newsdesk - Mar 12, 2024, 8:14AM
Enfusion Q4 2023 Adj EPS $0.04 Misses $0.05 E...
Benzinga Newsdesk - Mar 12, 2024, 8:05AM
Earnings Scheduled For March 12, 2024
Benzinga Insights - Mar 12, 2024, 5:35AM

Monday, March 11, 2024

Earnings Outlook For Enfusion
Benzinga Insights - Mar 11, 2024, 11:02AM

Wednesday, March 06, 2024

Major Purchase Alert: Oleg Movchan Invests $120K In Enfusion Stock
Benzinga Insights - Mar 6, 2024, 10:00AM

Wednesday, February 28, 2024

Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
Anusuya Lahiri - Feb 28, 2024, 3:11PM
Goldman Sachs Downgrades Enfusion to Sell, Lo...
Benzinga Newsdesk - Feb 28, 2024, 6:03AM

Tuesday, January 30, 2024

JP Morgan Downgrades Enfusion: Here's What You Need To Know
Benzinga Insights - Jan 30, 2024, 12:00PM
Enfusion shares are trading lower after JP Mo...
Benzinga Newsdesk - Jan 30, 2024, 11:45AM
JP Morgan Downgrades Enfusion to Underweight,...
Benzinga Newsdesk - Jan 30, 2024, 5:47AM

Tuesday, January 02, 2024

This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts
Avi Kapoor - Jan 2, 2024, 9:35AM

Wednesday, December 20, 2023

Piper Sandler Maintains Neutral on Enfusion, ...
Benzinga Newsdesk - Dec 20, 2023, 2:18PM

Tuesday, December 19, 2023

Enfusion Chief Executive Officer Trades $1.00M In Company Stock
Benzinga Insights - Dec 19, 2023, 10:02AM

Wednesday, December 06, 2023

Insider Unloading: Oleg Movchan Sells $1.51M Worth Of Enfusion Shares
Benzinga Insights - Dec 6, 2023, 10:01AM

Wednesday, November 29, 2023

Massive Insider Trade At Enfusion
Benzinga Insights - Nov 29, 2023, 10:01AM

Monday, November 20, 2023

Enfusion Announces Appointment Of Neal Pawar ...
Benzinga Newsdesk - Nov 20, 2023, 8:16AM

Tuesday, November 07, 2023

UBS Initiates Coverage On Enfusion with Neutr...
Benzinga Newsdesk - Nov 7, 2023, 8:52AM
Enfusion Q3 EPS $0.02 Misses $0.05 Estimate, ...
Benzinga Newsdesk - Nov 7, 2023, 7:39AM
Earnings Scheduled For November 7, 2023
Benzinga Insights - Nov 7, 2023, 6:34AM

Wednesday, August 09, 2023

Goldman Sachs Maintains Neutral on Enfusion, ...
Benzinga Newsdesk - Aug 9, 2023, 11:45AM
Morgan Stanley Maintains Overweight on Enfusi...
Benzinga Newsdesk - Aug 9, 2023, 8:50AM

Tuesday, August 08, 2023

Enfusion shares are trading lower after the c...
Benzinga Newsdesk - Aug 8, 2023, 12:36PM
Enfusion Sees FY23 Revenue $170M-$175M Vs $18...
Benzinga Newsdesk - Aug 8, 2023, 8:39AM
Enfusion Q2 EPS $0.01 Misses $0.05 Estimate, ...
Benzinga Newsdesk - Aug 8, 2023, 7:52AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved